United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - angelica sinensis root (unii: b66f4574ug) (angelica sinensis root - unii:b66f4574ug), american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), silver nitrate (unii: 95it3w8jze) (silver cation - unii:57n7b0k90a), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), capsicum (unii: 00uk7646fg) (capsicum - unii:00uk7646fg), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1 - distress - mood - sadness formulated for associated symptoms such as irritability, grief, despondency, difficult concentration, oversensitivity and prolonged sadness. formulated for associated symptoms such as irritability, grief, despondency, difficult concentration, oversensitivity and prolonged sadness.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h), selenicereus grandiflorus stem (unii: 7114sv0myk) (selenicereus grandiflorus stem - unii:7114sv0myk), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), potassium carbonate (unii: bqn1b9b9ha) (carbonate ion - - for temporary relief of glandular swelling, tremors, numbness, dizziness, blurred vision, and night sweats, high blood pressure, pulse rapid; abdominal soreness, sore bowels flatulence, cannot bear sight or smell of food, nausea, gastritis, belching. for temporary relief of glandular swelling, tremors, numbness, dizziness, blurred vision and night sweats, high blood pressure, pulse rapid; abdominal soreness, sore bowels flatulence, cannot bear sight or smell of food, nausea, gastritis, belching.

United States - English - NLM (National Library of Medicine)

apotheca company - selenicereus grandiflorus stem (unii: 7114sv0myk) (selenicereus grandiflorus stem - unii:7114sv0myk), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic trioxide - unii:s7v92p67ho), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), toxicodendron pubescens leaf (unii: 6io182rp7a) (toxicodendron pubescens leaf - unii:6io182rp7a), sambucus n - to be determined by final processor to be determined by final processor

United States - English - NLM (National Library of Medicine)

nutritional specialties, inc. - garlic (unii: v1v998dc17) (garlic - unii:v1v998dc17), beef kidney (unii: 5hoc10fsic) (beef kidney - unii:5hoc10fsic), leonurus cardiaca whole (unii: 8nc0c2yxk0) (leonurus cardiaca - unii:8nc0c2yxk0), viscum album fruiting top (unii: bk9092j5mp) (viscum album fruiting top - unii:bk9092j5mp), gold (unii: 79y1949pyo) (gold - unii:79y1949pyo), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3), lycopodium clavatum spore (unii: c8 - aids in temporary relief of headaches, frequent nosebleeds, excess water retention, nausea and dizziness.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. aids in temporary relief of headaches, frequent nosebleeds, excess water retention, nausea and dizziness.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - micrurus corallinus venom (unii: v0s6h36980) (micrurus corallinus venom - unii:v0s6h36980), apis mellifera (unii: 7s82p3r43z) (apis mellifera - unii:7s82p3r43z), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), lytta vesicatoria (unii: 3q034ro3bt) (lytta vesicatoria - unii:3q034ro3bt), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), colchicum autumnale bulb (unii: 993qhl78e6) (colchicum autumnale bulb - unii:993qhl78e6), convallaria majalis (unii: qhh4hvf5qe) (convallaria majalis - unii:qhh4hvf5qe), crotalus horridus horridus venom (unii: yha2xlj956) (crotalus horridus horridus venom - unii:yha2xlj956), digitalis (unii: f1t8qt9u8b) (digitalis - unii:f1t8qt9u8b), lachesis muta venom (unii: vsw71ss07i) (lachesis muta venom - unii:vsw71ss07i), mercury (unii: fxs1by2pgl) (mercury - unii:fxs1by2pgl), naja naja venom (unii: zz4ag7l7vm) (naja naja venom - unii:zz4ag7l7vm), sodium carbonate (unii: 45p3261c7t) (carbonate ion - unii:7ujq5ope7d), sodium sulfate (unii: 0ypr65r21j) (sodium sulfate anhydrous - unii:36kcs0r750), toxicodendron pubescens leaf (unii: 6io182rp7a) (toxicodendron pubescens leaf - unii:6io182rp7a), sambucus nigra flowering top (unii: ct03bsa18u) (sambucus nigra flowering top - unii:ct03bsa18u), strophanthus hispidus seed (unii: mo892vi77k) (strophanthus hispidus seed - unii:mo892vi77k), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), vipera berus venom (unii: 0oro6nca4m) (vipera berus venom - unii:0oro6nca4m), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), arctium lappa root (unii: 597e9bi3z3) (arctium lappa root - unii:597e9bi3z3), solidago virgaurea flowering top (unii: 5405k23s50) (solidago virgaurea flowering top - unii:5405k23s50), taraxacum officinale (unii: 39981fm375) (taraxacum officinale - unii:39981fm375), urtica urens (unii: ihn2nq5of9) (urtica urens - unii:ihn2nq5of9), juniper berry (unii: o84b5194rl) (juniper berry - unii:o84b5194rl) - formulated for associated symptoms such as skin discoloration, discomfort and swelling. formulated for associated symptoms such as skin discoloration, discomfort and swelling.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - spironolactone, quantity: 100 mg - tablet, film coated - excipient ingredients: macrogol 400; maize starch; hypromellose; calcium sulfate dihydrate; povidone; magnesium stearate; titanium dioxide; purified water; iron oxide yellow; iron oxide red; industrial methylated spirit; flavour - essential hypertension; oedematous disorders such as oedema and ascites of congestive cardiac failure, cirrhosis of the liver, nephrotic syndrome; diagnosis and treatment of primary hyperaldosteronism; as adjunctive therapy in malignant hypertension; in diuretic induced hypokalaemia when other measures are considered inappropriate or inadequate; prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate, hirsutism. essential hypertension: aldactone, when used alone, is effective in lowering both systolic and diastolic blood pressure. aldactone improves the hypotensive action of thiazide diuretics while at the same time reducing or preventing potassium loss due to the thiazide. aldactone enhances the effectiveness of other antihypertensive agents such as beta blockers, vasodilators etc. congestive cardiac failure: aldactone, when used alone, is effective in the management of oedema and sodium retention associated with congestive cardiac failure. aldactone may be used in combination with a thiazide or other conventional diuretics for achieving diuresis in patients whose oedema is resistant to a thiazide or other conventional diuretics. unlike conventional diuretics aldactone does not produce hypokalaemia. when administered with a thiazide or other conventional diuretics aldactone offsets hypokalaemia induced by these diuretics. the prevention of potassium loss is particularly important in the treatment of digitalized patients since digitalis intoxication may be precipitated if hypokalaemia is induced by conventional diuretic therapy. hepatic cirrhosis with ascites and oedema: aldactone when used alone is frequently adequate for the relief of ascites and oedema associated with hepatic cirrhosis. aldactone provides a mild and even diuresis and prevents excessive potassium excretion caused by thiazide diuretics thus avoiding possible precipitation of hepatic coma. nephrotic syndrome : although glucocorticoids, whose anti inflammatory activity appears to benefit the primary pathologic process in the renal glomerulus, should probably be employed first, aldactone either alone or in combination with a conventional diuretic is useful for inducing diuresis. primary hyperaldosteronism: aldactone may be used to establish the diagnosis of primary hyperaldosteronism by therapeutic trial. aldactone may also be used for the short term pre operative treatment of patients with primary hyperaldosteronism, long term maintenance therapy for patients with discrete aldosterone producing adrenal adenomas who are judged to be poor operative risks (or who decline surgery), and the long term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). hirsutism in females: aldactone is effective in the treatment of females with hirsutism, an androgen related increase in facial and body hair. a reduction in hair growth, hair shaft diameter and hair pigmentation is seen. use of aldactone should be considered only after all other alternatives of non drug therapy have been explored. for women of child bearing age, see contraindications and precautions, use in pregnancy.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - spironolactone, quantity: 25 mg - tablet, film coated - excipient ingredients: macrogol 400; hypromellose; maize starch; calcium sulfate dihydrate; magnesium stearate; povidone; flavour; titanium dioxide; purified water; iron oxide yellow; iron oxide red; industrial methylated spirit - essential hypertension; oedematous disorders such as oedema and ascites of congestive cardiac failure, cirrhosis of the liver, nephrotic syndrome; diagnosis and treatment of primary hyperaldosteronism; as adjunctive therapy in malignant hypertension; in diuretic induced hypokalaemia when other measures are considered inappropriate or inadequate; prophylaxis of hypokalaemia in patients taking digitalis when other measures are considered inadequate or inappropriate, hirsutism. essential hypertension: aldactone, when used alone, is effective in lowering both systolic and diastolic blood pressure. aldactone improves the hypotensive action of thiazide diuretics while at the same time reducing or preventing potassium loss due to the thiazide. aldactone enhances the effectiveness of other antihypertensive agents such as beta blockers, vasodilators etc. congestive cardiac failure: aldactone, when used alone, is effective in the management of oedema and sodium retention associated with congestive cardiac failure. aldactone may be used in combination with a thiazide or other conventional diuretics for achieving diuresis in patients whose oedema is resistant to a thiazide or other conventional diuretics. unlike conventional diuretics aldactone does not produce hypokalaemia. when administered with a thiazide or other conventional diuretics aldactone offsets hypokalaemia induced by these diuretics. the prevention of potassium loss is particularly important in the treatment of digitalized patients since digitalis intoxication may be precipitated if hypokalaemia is induced by conventional diuretic therapy. hepatic cirrhosis with ascites and oedema: aldactone when used alone is frequently adequate for the relief of ascites and oedema associated with hepatic cirrhosis. aldactone provides a mild and even diuresis and prevents excessive potassium excretion caused by thiazide diuretics thus avoiding possible precipitation of hepatic coma. nephrotic syndrome : although glucocorticoids, whose anti inflammatory activity appears to benefit the primary pathologic process in the renal glomerulus, should probably be employed first, aldactone either alone or in combination with a conventional diuretic is useful for inducing diuresis. primary hyperaldosteronism: aldactone may be used to establish the diagnosis of primary hyperaldosteronism by therapeutic trial. aldactone may also be used for the short term pre operative treatment of patients with primary hyperaldosteronism, long term maintenance therapy for patients with discrete aldosterone producing adrenal adenomas who are judged to be poor operative risks (or who decline surgery), and the long term maintenance therapy for patients with bilateral micro or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). hirsutism in females: aldactone is effective in the treatment of females with hirsutism, an androgen related increase in facial and body hair. a reduction in hair growth, hair shaft diameter and hair pigmentation is seen. use of aldactone should be considered only after all other alternatives of non drug therapy have been explored. for women of child bearing age, see contraindications and precautions, use in pregnancy.

United States - English - NLM (National Library of Medicine)

guna spa - ferric picrate (unii: kzm8zry36a) (ferric cation - unii:91o4lml611), chaste tree (unii: 433osf3u8a) (chaste tree - unii:433osf3u8a), barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln), chimaphila umbellata (unii: wck21a9w9j) (chimaphila umbellata - unii:wck21a9w9j), clematis recta flowering top (unii: 396421sp9f) (clematis recta flowering top - unii:396421sp9f), conium maculatum flowering top (unii: q28r5gf371) (conium maculatum flowering top - unii:q28r5gf371), digitalis (unii: f1t - chaste tree 6 [hp_x] in 30 ml - agnus castus        6x    incontinence baryta carbonica    12x 30x    painful urination chimaphila umbellata    6x    detoxification clematis erecta        3x    antioxidant conium maculatum    12x 30x    antioxidant digitalis purpurea    12x 30x    relieves urinary irritation ferrum picrinicum    12x 30x    sudden urge to urinate interferon gamma    4c    antioxidant interleukin 10        4c    painful urination interleukin 2        4c    painful urination melatonin        4c    hormonal regulation prostate        200x    painful urination sabal serrulata        3x    painful urination selenium metallicum    12x 30x    slowed start of urination staphysagria        12x 30x    painful urination tgf beta        4c    painful urination thuja occidentalis    12x 30x    slowed start of urinatio

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - scutellaria lateriflora whole (unii: 7bp4dh5pdc) (scutellaria lateriflora whole - unii:7bp4dh5pdc), delphinium staphisagria seed (unii: 00543ap1jv) (delphinium staphisagria seed - unii:00543ap1jv), datura stramonium (unii: g6w4f0v8z3) (datura stramonium - unii:g6w4f0v8z3), theridion curassavicum (unii: 9z8d3hem8l) (theridion curassavicum - unii:9z8d3hem8l), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), ginkgo (unii: 19fuj2c58t) (ginkgo - unii:19fuj2c58t), hyperi - formulated for associated symptoms such as lack of focus, anxiety, anger, impulsiveness, restlessness and sensitivity. formulated for associated symptoms such as lack of focus, anxiety, anger, impulsiveness, restlessness and sensitivity.

United States - English - NLM (National Library of Medicine)

newton laboratories, inc. - delphinium staphisagria seed (unii: 00543ap1jv) (delphinium staphisagria seed - unii:00543ap1jv), datura stramonium (unii: g6w4f0v8z3) (datura stramonium - unii:g6w4f0v8z3), theridion curassavicum (unii: 9z8d3hem8l) (theridion curassavicum - unii:9z8d3hem8l), echinacea, unspecified (unii: 4n9p6cc1dx) (echinacea, unspecified - unii:4n9p6cc1dx), ginkgo (unii: 19fuj2c58t) (ginkgo - unii:19fuj2c58t), scutellaria lateriflora whole (unii: 7bp4dh5pdc) (scutellaria lateriflora whole - unii:7bp4dh5pdc), hyperi - formulated for associated symptoms such as lack of focus, anxiety, anger, impulsiveness, restlessness and sensitivity. formulated for associated symptoms such as lack of focus, anxiety, anger, impulsiveness, restlessness and sensitivity.